Thank you, Selwyn, and good morning, everyone. I encourage everyone to read the earnings press release issued this morning as well as 10-Q that we filed later today. Let me now provide a review of our fiscal second quarter and 6-month financial results. Net sales for the fiscal '23 second quarter were $172.5 million representing a 6.6% increase compared with $161.8 million in the prior year, which excludes $13.7 million of core revenue due to a realignment of inventory at customer distribution centers with sales benefits evolving as product mix changes. Gross profit for the fiscal '23 second quarter was $26.5 million compared with $36 million a year earlier. Gross profit for the quarter was impacted by noncash items as well as cash items. Let me provide details for each, and then I'll provide further details on the impact on each additional line item but you can further understand the underlying fundamentals between periods and the opportunities to enhance profitability. The noncash items reflect core and finished good premium amortization, and revaluation of cores on customer shelves, which are unique to certain of our products and required by GAAP. The total of these noncash items in the quarter was approximately $4.3 million. A more detailed explanation of core accounting is available on our website, and I would encourage anyone with questions about this topic to review the video. In terms of cash items, we incurred higher freight costs in excess of customer freight surcharges that we already implemented. In addition, there were remaining higher tariffs due to the shutdown of Malaysia that impacted our facilities and other related supply chain disruption costs. The total cash impact of these [indiscernible] costs, including freight, tariffs and other related costs related to supply chain disruptions on gross profit, was $3.7 million compared with $5.5 million a year ago as referenced in Exhibit 3 of this morning's earnings press release. We are encouraged that these costs are decreasing. Before moving on, I should note there were no ramp-up and transition expenses related to our Mexico expansion this quarter compared with $797,000 in the prior year second quarter. We are pleased that brake calipers operations are increasing nicely, and we expect greater sales volume and related benefits with enhanced financial performance as someone previously referenced. Non-adjusted second quarter gross profit as a percentage of net sales was 15.4% compared with 20.5% a year earlier. Gross margin was impacted by 2.5% and for the previously mentioned noncash items as well as 2.1% from the previously mentioned cash items from transitory costs related to supply chain disruptions. Additionally, gross margin for the quarter was impacted by unusual supply chain shortages of critical semiconductor chips for the company's diagnostic products and critical components for heavy-duty products. We continue to experience extraordinary global supply chain challenges and inflationary costs. While our most recent price increases were not fully in effect. In summary, gross margin for the fiscal '23 second quarter compared with the prior year was impacted by higher inflationary costs, unusual supply chain shortages of critical components for the company's diagnostic and heavy-duty products, changes in product mix and the benefit of core revenue in the prior year due to a realignment of inventory at certain customer distribution centers. Gross margin is expected to benefit from certain price increases that went into effect at the end of the current fiscal quarter as well as anticipated future price increases discussed earlier. Moving on, operating expenses were down $1.7 million for the quarter to $24.7 million from $26.4 million in the prior year period. This includes the lower noncash expense of $2.8 million with a mark-to-market foreign exchange impact of lease liabilities and forward contracts compared with the prior year and $900,000 of increased noncash expense due to foreign currency transactions. We reported a net loss of $6.5 million or $0.34 per share. Results were impacted by items that totaled $8.9 million or $0.46 per share as detailed in Exhibit 1 of this morning's earnings press release. Results reflect the impact of noncash items totaling $5 million or $0.26 per share including core and finished goods premium amortization and revaluation of cores and customer shelves totaling $4.3 million as previously explained. Noncash items also included a loss of $1.1 million for the foreign exchange impact of lease liabilities and forward contracts. Cash items that impacted results include transitory costs related to supply chain disruption totaling $3.9 million or $0.20 per share. In addition to debt items, results for the quarter were primarily impacted by unusual supply chain shortages of critical components for the company's diagnostic products, and heavy-duty products as referenced previously. I should note that we have implemented cost reduction initiatives throughout the company, including travel, outside services, labor costs and overall cost-saving opportunities, which are expected to enhance profitability. Additionally, results for the fiscal second quarter were also impacted by higher interest expenses primarily due to higher interest rates compared with the prior year. Interest expense was $9.3 million compared with $3.6 million for last year, significantly due to higher interest rates on the accounts receivable discount programs offered by our customers. I should emphasize that the large interest expense incurred in the second quarter was primarily driven by a sharp rise in interest rates of 3.3% compared with the prior year, but the accounts receivable discount program offered by our customers. This increase is nearly triple, the discount rate the company paid an interest expense in the prior year period. In order to address this significant rise in interest rates, we are implementing price increases, which are expected to help offset these higher rates and certain costs as noted previously. We are also focused on improving cash flow to pay down borrowings. Additionally, income tax benefit was $914,000 compared with $2.3 million income tax expense for the prior year period. As you also mentioned that the effective tax rate was affected in part due to specific foreign jurisdictions from which we did not expect to recognize the benefit of losses. However, we expect these losses will be realized against future profits, which will benefit future tax rates. Net income was $3.7 million or $0.19 per diluted share in the year ago period. Results a year earlier were impacted by a total of $9.6 million or $0.49 per diluted share. These include noncash items totaling $8.1 million or $0.41 per diluted share, including a noncash loss of 39 -- $3.9 million or $0.20 per diluted share on a pretax basis, for the foreign exchange impact of lease liabilities and forward contracts and cash items totaling $1.5 million or $0.08 per diluted share, primarily transitory costs related to supply chain disruptions. EBITDA for second quarter was $4.9 million. EBITDA was impacted by $6.7 million of noncash items as well as $5.1 million in cash items, primarily due to the transitory cost related to supply chain disruptions. EBITDA before the impact of noncash and cash items mentioned above, was $16.7 million for the second quarter. In addition to the above items, EBITDA for the quarter was impacted by unusual supply chain shortages of critical components for the company's diagnostic products and heavy-duty products as referenced previously. EBITDA for the prior year second quarter was $12.8 million. EBITDA a year on was impacted by $10.8 million of noncash items as well as $2 million of cash expenses, primarily transitory costs related to supply chain disruption. EBITDA before the impact of noncash and cash items, mentioned above, was $25.5 million for the prior year second quarter. Now let me discuss the 6 months results. Net sales for the fiscal '23 6-month period were $336.5 million, representing an 8.3% increase compared with $310.8 million in the prior year which excludes $13.7 million in core revenue due to a realignment of inventory at customer distribution centers with sales benefits evolving as product mix changes. Gross profit for the fiscal '23 6-month period was $56.8 million compared with $59.5 million a year earlier. Gross profit as a percentage of net sales for the fiscal '23 6-month period was 16.9% compared with 18.3% a year earlier. Gross margin for fiscal '23 6-month period was impacted by 2.4% of noncash items, and 1.8%, primarily by transitory supply chain disruptions as detailed in Exhibit 4 in this morning's earnings press release. Gross margin for the fiscal '23 6-month period compared with the prior year was impacted by various items discussed previously for the quarter. Net loss for the fiscal '23 6-month period was $6.7 million or $0.35 per share compared with net income of $4.5 million or $0.23 per diluted share a year ago. Results were impacted by a total of $15.8 million or $0.83 per share. These include noncash items totaling $9.2 million or $0.48 per share and cash items totaling $6.6 million or $0.35 per share, primarily transitory costs related to supply chain disruption as detailed in Exhibit 2. In addition to the above items, results for the 6-month period were primarily impacted by unusual supply chain shortages of critical components for the company's diagnostic product and heavy-duty products as referenced previously. EBITDA for the fiscal '23 26-month period was $15.4 million. EBITDA was impacted by $12.2 million of noncash items, as well as $8.9 million in cash items, primarily due to the transitory cost pressures related to supply chain disruption. EBITDA before the impact of noncash and cash items, mentioned above, was $36.5 million for the current period. In addition to the above items, EBITDA for the 6-month period was impacted by unusual supply chain shortages, optical components for the company's diagnostic products and heavy-duty products, as previously -- as referenced previously. EBITDA for the prior year fiscal '22 6-month period was $21.7 million, EBITDA was impacted by $13.4 million of noncash items as well as $9.3 million in cash items, primarily due to transitory cost pressures related to supply chain disruptions. EBITDA before the impact of noncash and cash items, mentioned above, was $44.4 million for the prior year period. Now we will move on to cash flow and key corporate items. Net cash used in operating activities during the fiscal second quarter was $16 million versus $19.6 million cash used in operating activities in the prior year period. This reflects working capital requirements to support solid sales growth, including increases in accounts receivable. We do expect to generate cash from operating activities for fiscal '23. We expect to generate an increase in operating profit on a year-over-year basis, supported by organic growth from customer demand, introduction of the new product categories, price increases and operating efficiencies from our footprint expansion. Our return on invested capital on a pretax basis at September 30, 2022, was 15.1% compared with 21.1% a year earlier. As our investments bear fruit, we expect to realize further benefit from the expansion of our Mexican operations and the launch of our new brake categories with expectations of increased returns from both new and existing product lines. Our net debt at the end of the quarter was approximately $170.2 million, while total cash and availability on the revolving credit facility was approximately $76.9 million. Lastly, we recently entered into a fourth amendment to our credit facility to modify the covenants to match the timing of implementing price increases to address inflationary costs and nearly tripling of interest rates. For further explanation on the reconciliation of items that impact results and non-GAAP financial measures, please refer to Exhibits 1-5 in this morning's earnings press release. I would now like to open the line for questions.